Metabolic Maintenance of Immune Memory with Age

Define the metabolic checkpoints that preserve recall capacity without amplifying inflammaging. Boundary domains: immunometabolism, cell-state-reprogramming. Representative papers: Targeting memory T cell metabolism to improve immunity.; Immunosenescence: Aging and Immune System Decline.; IL-7: Comprehensive review.

The metabolic fitness of long-lived memory lymphocytes declines with aging, compromising recall responses during reinfection or vaccination. Memory T cells rely on fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS) for quiescent maintenance, switching to aerobic glycolysis upon re-stimulation. During aging, mitochondrial dysfunction, increased ROS production, and impaired mitophagy erode this metabolic flexibility. Similarly, long-lived plasma cells and memory B cells depend on mitochondrial health for sustained antibody secretion; aged bone marrow niches provide suboptimal metabolic support. Key metabolic checkpoints implicated include the AMPK–mTORC1 axis, NAD+ availability, and fatty acid import via CPT1. Metformin—an AMPK activator—has demonstrated capacity to extend healthspan and improve vaccine responses in older adults by restoring metabolic signaling, and repurposing potential for immune aging is under active investigation (Metformin: mechanisms and repurposing, Nature Reviews Endocrinology 2023).

The critical gap is understanding which specific metabolic checkpoints preserve recall capacity without amplifying inflammaging. Restoring FAO in aged T cells enhances recall responses in mouse models, but the same interventions risk driving pro-inflammatory metabolic programs in innate immune cells, exacerbating NLRP3 inflammasome activation and IL-1β/IL-18 secretion—a key mechanism of inflammaging (NLRP3 inflammasome regulatory mechanisms, Nature Immunology 2021). Defining whether memory lymphocyte-selective metabolic interventions are achievable, or whether systemic metabolic reprogramming inevitably affects immune homeostasis globally, is unresolved. Trained immunity induction itself rewires monocyte immunometabolism (Warburg effect, glutamine catabolism), and these same metabolic shifts drive inflammaging when chronically sustained (Defining trained immunity, Nature Reviews Immunology 2020).

Metformin and rapamycin trials are beginning to address systemic metabolic interventions for immune aging, and caloric restriction mimetics show promise in animal models. NAD+ precursor supplementation (NMN, NR) is being tested for restoring mitochondrial function in aged lymphocytes. Whether these interventions selectively benefit immune memory compartments or indiscriminately alter immune set points requires carefully stratified clinical trials with immune-specific endpoints, including antigen-specific recall assays and transcriptomic profiling of memory cell subsets before and after treatment.